Hematological Malignancies

GHSG HD9 trial OS by treatment arm

Percentage 0.0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1.0

11%

A (75%) B (80%) C (86%)

p <0.001

0

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

Years

Engert et al; JCO 2009